Clinical Trial Update: STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (NCT05843578) is evaluating AGMB-129 for safety, tolerability, pharmacokinetics and pharmacodynamics in patients with Crohn's disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• AGMB-129

Snippet

Sponsor: Agomab Spain S.L.U. | Conditions: Fibrostenotic Crohn's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING